Corporate dealmaking is heating up across the globe, with a flurry of talks and signed agreements spanning private banking in Spain, industrial AI software, and multi-billion-dollar asset sales in energy and metals. While no single mega-merger dominates, the breadth of activity shows how companies are using acquisitions and divestitures to reposition themselves faster than they could by building from scratch.
Banking and Finance: ING Targets Spain, Perpetual Rejects EQT
In European banking, Dutch lender ING is close to acquiring a 40% stake in Singular Bank, a move that would give it a foothold in Spain's private-banking market. Private banking caters to high-net-worth individuals, offering tailored wealth management and investment services. For ING, the deal is a targeted way to enter a profitable niche without building a new business from the ground up.
Meanwhile, in Australia, asset manager Perpetual has rejected a non-binding approach from private equity firm EQT that valued the company at A$2.45 billion. Perpetual's board deemed the offer inadequate, but the approach signals ongoing interest from buyout firms in financial services firms with steady fee income. The rejection doesn't rule out a higher bid or other suitors, so investors will watch for further developments.
Energy and Metals: Big-Ticket Asset Sales Reshape Portfolios
The largest price tags are appearing in energy and metals, where companies are selling off assets to sharpen their focus. Shell has agreed to sell its Gulf of America assets for $1.7 billion. The sale is part of Shell's broader strategy to streamline its portfolio and concentrate on higher-return projects, a common theme among oil majors as they balance fossil fuel cash flows with investments in lower-carbon energy.
In a separate deal, private equity giant KKR has agreed to buy EDF's North American renewables unit for $4.2 billion. This acquisition gives KKR a substantial portfolio of wind, solar, and other renewable energy assets in the U.S. and Canada. For EDF, the French state-owned utility, the sale frees up capital to invest in its core European operations and nuclear fleet. The deal also highlights the growing appetite among private equity firms for renewable energy infrastructure, which offers long-term, stable cash flows. (For more on KKR's recent activity, see our coverage of the French deal spree.)
Perhaps the most consequential deal for commodity investors is South32's agreement to sell most of its aluminum assets to Alcoa for an implied enterprise value of up to $5.6 billion. South32, a diversified miner spun off from BHP, is under new leadership that is pushing the company toward copper, a metal seen as critical for electrification and renewable energy infrastructure. By offloading aluminum-heavy operations, South32 reduces its exposure to aluminum price swings and increases its focus on copper, which is often viewed as a long-term growth metal due to its use in power grids and electric vehicles.
For Alcoa, the acquisition is the mirror image: it gains a larger aluminum footprint, making its profits and investor expectations more sensitive to the aluminum cycle. The deal also frees up cash and management attention at South32 that can be redeployed into copper growth, reinforcing the shift. Investors will be watching how both companies execute on these strategic pivots.
Tech and Biotech: AI Software and Experimental Drugs
Outside of finance and commodities, Schneider Electric has agreed to buy Cognite, a company that sells industrial AI and data tools. Cognite's software helps factories, oil rigs, and other industrial sites use data to improve efficiency and reduce downtime. For Schneider, which specializes in energy management and automation, the acquisition adds digital capabilities that complement its hardware business.
In the pharmaceutical sector, French drugmaker Ipsen has agreed to acquire Memo Therapeutics, adding an experimental antibody treatment that is still in mid-stage clinical testing. The deal gives Ipsen a potential new therapy for diseases like cancer or autoimmune disorders, though the drug is years away from potential approval. Such acquisitions are common in biotech, where larger companies buy promising candidates from smaller developers to fill their pipelines.
What It Means for Investors
This wave of dealmaking shows that companies are actively reshaping their portfolios, often in response to shifting market trends like the energy transition, digitalization, and demographic changes in wealth management. For investors, the key takeaway is that these moves can significantly alter a company's risk profile and growth prospects.
When a miner like South32 sells a major set of operations, it doesn't just change its size; it changes what drives its results. By reducing aluminum exposure, South32's earnings will become less tied to aluminum prices and more tied to copper, which is often treated as a long-run "electrification" metal. That shift could attract investors who want exposure to the green energy theme, while those who preferred the aluminum cycle may look elsewhere. Similarly, Alcoa's enlarged aluminum footprint means its profits will be more sensitive to aluminum price movements, which could increase volatility.
For banking investors, ING's move into Spanish private banking is a small but strategic step that could boost fee income and diversify its revenue base. Perpetual's rejection of EQT's bid suggests the board believes the company is worth more, but it also opens the door to potential higher offers or activist pressure.
Overall, the breadth of activity—from banks to biotech to big oil—indicates that corporate leaders see opportunities to create value through M&A, even in a mixed economic environment. Investors should pay attention to how these deals close and how the companies integrate their new assets, as execution will ultimately determine whether the strategic bets pay off.
